Insulin Glargine + Lixisenatide
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Insulin Glargine
insulin-glargine - Lixisenatide
lixisenatide
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| Soliqua 100/33CAMXUS | 100 unit / 0.033 mg | SANOFI-AVENTIS CANADA INC |
| SULIQUA PRECARGADAES | 100 IU / 0.033 mg / 0.05 mg | Sanofi Winthrop Industrie |
| insulina glargina + lixisenatidaES | 100 IU / 0.033 mg / 0.05 mg | Sanofi Winthrop Industrie |
| Soliqua solution for injection 100 units+33μgTW | — | 賽諾菲股份有限公司 |
| SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100UNITS/ML + 50MCG/MLSG | 100 unit/mL / 50 mcg/mL / 33 mcg/mL | SANOFI-AVENTIS SINGAPORE PTE. LTD. |
| insulin glargine and lixisenatideUS | 100 unit / 0.033 mg | Sanofi-Aventis U.S. LLC |
| Suliqua 100units/ml / 50micrograms/ml solution for injection 3ml pre-filled SoloStar pensGB | 3 mL | Sanofi |
| Insulin glargine 100units/ml / Lixisenatide 50micrograms/ml solution for injection 3ml pre-filled disposable devicesGB | 3 mL | Sanofi |
| Suliqua 100units/ml / 33micrograms/ml solution for injection 3ml pre-filled SoloStar pensGB | 3 mL | Sanofi |
| Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devicesGB | 3 mL | Sanofi |
| 爽胰達注射劑100單位+33微克TW | — | 賽諾菲股份有限公司 |
| 爽胰達注射劑100單位+50微克TW | — | 賽諾菲股份有限公司 |
| SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML + 33 MICROGRAMS/MLHK | — | SANOFI HONG KONG LIMITED |
| SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML + 50 MICROGRAMS/MLHK | — | SANOFI HONG KONG LIMITED |
| SuliquaEU | — | Sanofi Winthrop Industrie |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.